Saved in:
Bibliographic Details
Main Authors: Banerjee, Ayan, Kamboj, Payal, Gupta, Sandeep
Format: Preprint
Published: 2024
Subjects:
Online Access:https://arxiv.org/abs/2411.10983
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1866913579812257792
author Banerjee, Ayan
Kamboj, Payal
Gupta, Sandeep
author_facet Banerjee, Ayan
Kamboj, Payal
Gupta, Sandeep
contents Precision medicine is a promising approach for accessible disease diagnosis and personalized intervention planning in high-mortality diseases such as coronary artery disease (CAD), drug-resistant epilepsy (DRE), and chronic illnesses like Type 1 diabetes (T1D). By leveraging artificial intelligence (AI), precision medicine tailors diagnosis and treatment solutions to individual patients by explicitly modeling variance in pathophysiology. However, the adoption of AI in medical applications faces significant challenges, including poor generalizability across centers, demographics, and comorbidities, limited explainability in clinical terms, and a lack of trust in ethical decision-making. This paper proposes a framework to develop and ethically evaluate expert-guided multi-modal AI, addressing these challenges in AI integration within precision medicine. We illustrate this framework with case study on insulin management for T1D. To ensure ethical considerations and clinician engagement, we adopt a co-design approach where AI serves an assistive role, with final diagnoses or treatment plans emerging from collaboration between clinicians and AI.
format Preprint
id arxiv_https___arxiv_org_abs_2411_10983
institution arXiv
publishDate 2024
record_format arxiv
spellingShingle Framework for developing and evaluating ethical collaboration between expert and machine
Banerjee, Ayan
Kamboj, Payal
Gupta, Sandeep
Computer Vision and Pattern Recognition
Precision medicine is a promising approach for accessible disease diagnosis and personalized intervention planning in high-mortality diseases such as coronary artery disease (CAD), drug-resistant epilepsy (DRE), and chronic illnesses like Type 1 diabetes (T1D). By leveraging artificial intelligence (AI), precision medicine tailors diagnosis and treatment solutions to individual patients by explicitly modeling variance in pathophysiology. However, the adoption of AI in medical applications faces significant challenges, including poor generalizability across centers, demographics, and comorbidities, limited explainability in clinical terms, and a lack of trust in ethical decision-making. This paper proposes a framework to develop and ethically evaluate expert-guided multi-modal AI, addressing these challenges in AI integration within precision medicine. We illustrate this framework with case study on insulin management for T1D. To ensure ethical considerations and clinician engagement, we adopt a co-design approach where AI serves an assistive role, with final diagnoses or treatment plans emerging from collaboration between clinicians and AI.
title Framework for developing and evaluating ethical collaboration between expert and machine
topic Computer Vision and Pattern Recognition
url https://arxiv.org/abs/2411.10983